Thyroid News and Research

RSS

FDA approves first therapy for patients with rare tumors of the adrenal gland

The U.S. Food and Drug Administration today approved Azedra (iobenguane I 131) injection for intravenous use for the treatment of adults and adolescents age 12 and older with rare tumors of the adrenal gland (pheochromocytoma or paraganglioma) that cannot be surgically removed (unresectable), have spread beyond the original tumor site and require systemic anticancer therapy.

31 Jul 2018

Novartis' new drug combination receives positive CHMP opinion for treating stage III BRAF mutant melanoma

Novartis today announced the Committee for Medicinal Products for Human Use of the European Medicines Agency has adopted a positive opinion recommending approval of Tafinlar® in combination with Mekinist® for the adjuvant treatment of adult patients with stage III melanoma with a BRAF V600 mutation, following complete resection.

27 Jul 2018

Study shows spillover effect of evidence-based opioid prescribing for major procedures

To curb the use of opioids after major elective operations and prevent these pain relievers from falling into the wrong hands, surgeons at the University of Michigan developed prescribing recommendations based on published medical evidence for one operation, gall bladder removal, and then discovered a spillover effect that led them to prescribe roughly 10,000 fewer pills for other major operations, according to study results appearing as an "article in press" on the website of the Journal of the American College of Surgeons ahead of print.

27 Jul 2018

Experts highlight the need to avoid overdiagnosis and 'excessive' treatment of thyroid cancer

More Americans are being diagnosed with thyroid cancer than ever before--over the past 25 years its incidence has tripled.

26 Jul 2018

CNDA approves KEYTRUDA for treatment of advanced melanoma

Merck, known as MSD outside the United States and Canada, today announced that KEYTRUDA, Merck's anti-PD-1 therapy, has been approved by the China National Drug Administration for the treatment of adult patients with unresectable or metastatic melanoma following failure of one prior line of therapy.

26 Jul 2018

MicroRNA panel could categorize indeterminate thyroid nodule samples into malignant and benign

A panel of 19 microRNAs identified using next-generation sequencing could categorize indeterminate thyroid nodule samples into malignant and benign.

26 Jul 2018

How soon is soon enough to learn you have Alzheimer’s?

Jose Belardo of Lansing, Kan., spent most of his career in the U.S. Public Health Service. He worked on the front lines of disasters in such places as Haiti, Colombia, Nicaragua and the Dominican Republic. At home with his three kids and wife, Elaine, he’d always been unfailingly reliable, so when he forgot their wedding anniversary two years in a row, they both started to worry.

26 Jul 2018

Phase 3 study of KEYTRUDA monotherapy meets primary endpoint

Merck, known as MSD outside the United States and Canada, announced today that the pivotal Phase 3 KEYNOTE-048 trial investigating KEYTRUDA, Merck's anti-PD-1 therapy, for first-line treatment of recurrent or metastatic head and neck squamous cell carcinoma, met a primary endpoint of overall survival as monotherapy in patients whose tumors expressed PD-L1.

25 Jul 2018

Ferring announces FDA approval of ZOMACTON for injection in four new pediatric indications

Ferring Pharmaceuticals Inc. today announced that the U.S. Food and Drug Administration has approved ZOMACTON for injection in four additional pediatric indications

20 Jul 2018

People who survived cancer in adolescence may have higher risk of endocrine disease

An increased risk of endocrine diseases, such as thyroid disease, testicular dysfunction and diabetes, was associated with people who survived cancer as adolescents and young adults.

30 Jun 2018

Frequent handwashing and house cleaning can effectively lower exposure to flame retardants

Washing your hands and cleaning your house frequently may help to lower your contact with common flame-retardant chemicals, according to a new study by researchers at the Columbia Center for Children's Environmental Health at Columbia University's Mailman School of Public Health.

28 Jun 2018

Study shows increased risk of cancer among US flight attendants

A new study from Harvard T.H. Chan School of Public Health has revealed that several types of cancer are more common among US flight attendants than they are among the general population.

26 Jun 2018

Merck announces FDA acceptance of supplemental Biologics License Application for KEYTRUDA

Merck, known as MSD outside the United States and Canada, today announced that the U.S. Food and Drug Administration has accepted for standard review a new supplemental Biologics License Application for KEYTRUDA, Merck's anti-PD-1 therapy, as adjuvant therapy in the treatment of patients with resected, high-risk stage III melanoma and granted a Prescription Drug User Fee Act, or target action, date of February 16, 2019.

25 Jun 2018

$Study shows fat cells increase in size and number upon exposure to fracking chemicals$

Study shows fat cells increase in size and number upon exposure to fracking chemicals

Exposure to fracking chemicals and wastewater promotes fat cell development, or adipogenesis, in living cells in a laboratory, according to a new Duke University-led study.

21 Jun 2018

Medicare takes aim at boomerang hospitalizations of nursing home patients

"Oh my God, we dropped her!" Sandra Snipes said she heard the nursing home aides yell as she fell to the floor. She landed on her right side where her hip had recently been replaced.

13 Jun 2018

Special issue focuses on how endocrine-disrupting chemicals influence behavior

Rutgers School of Public Health Professor Dr. Emily Barrett, PhD, and North Carolina State University Professor Dr. Heather Patisaul, PhD, have guest edited a special issue of the journal Hormones and Behavior.

13 Jun 2018

Women with thyroid dysfunction during pregnancy face increased risk for gestational diabetes

Women with thyroid dysfunction in the first half of pregnancy face an increased risk for gestational diabetes, a form of diabetes that is typically diagnosed during the second trimester, according to a new study published in the Endocrine Society's Journal of Clinical Endocrinology & Metabolism.

8 Jun 2018

Study finds increase in lifestyle-related cancers over the past decade

Lifestyle-related cancers, such as lung, colorectal, and skin cancers, have increased globally over the past decade, according to the most comprehensive analysis of cancer-related health outcomes and patterns ever conducted.

4 Jun 2018

Opdivo plus low-dose Yervoy shows promising results in treating renal cell carcinoma patients

Bristol-Myers Squibb Company today announced patient-reported outcomes data from the Phase 3 CheckMate -214 trial in intermediate- and poor-risk patients with advanced renal cell carcinoma treated with the Immuno-Oncology combination Opdivo plus low-dose Yervoy versus sunitinib over a two-year follow-up period.

1 Jun 2018

Male thyroid cancer survivors face nearly 50% higher CVD risk than women, study suggests

Male thyroid cancer survivors have a nearly 50 percent higher risk of developing heart disease than women within five years of cancer diagnosis, according to a new study published in the Endocrine Society's Journal of Clinical Endocrinology & Metabolism.

30 May 2018

Thyroid News and Research

FDA approves first therapy for patients with rare tumors of the adrenal gland

Novartis' new drug combination receives positive CHMP opinion for treating stage III BRAF mutant melanoma

Study shows spillover effect of evidence-based opioid prescribing for major procedures

Experts highlight the need to avoid overdiagnosis and 'excessive' treatment of thyroid cancer

CNDA approves KEYTRUDA for treatment of advanced melanoma

MicroRNA panel could categorize indeterminate thyroid nodule samples into malignant and benign

How soon is soon enough to learn you have Alzheimer’s?

Phase 3 study of KEYTRUDA monotherapy meets primary endpoint

Ferring announces FDA approval of ZOMACTON for injection in four new pediatric indications

People who survived cancer in adolescence may have higher risk of endocrine disease

Frequent handwashing and house cleaning can effectively lower exposure to flame retardants

Study shows increased risk of cancer among US flight attendants

Merck announces FDA acceptance of supplemental Biologics License Application for KEYTRUDA

Study shows fat cells increase in size and number upon exposure to fracking chemicals

Medicare takes aim at boomerang hospitalizations of nursing home patients

Special issue focuses on how endocrine-disrupting chemicals influence behavior

Women with thyroid dysfunction during pregnancy face increased risk for gestational diabetes

Study finds increase in lifestyle-related cancers over the past decade

Opdivo plus low-dose Yervoy shows promising results in treating renal cell carcinoma patients

Male thyroid cancer survivors face nearly 50% higher CVD risk than women, study suggests

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News